Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain

L D Olson1, S W Shane, A A Karpas

  • 1Laboratory of Mycoplasma, Food and Drug Administration, Bethesda, Maryland 20892.

Insights

Monoclonal antibodies identified surface proteins of Mycoplasma hominis, revealing potential acylation and antigenic diversity among strains, despite a common 94-kDa protein target.

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Mycoplasma hominis is associated with various infections, including septic arthritis.
  • Understanding the antigenic properties of M. hominis is crucial for diagnostics and therapeutics.

Purpose of the Study:

  • To characterize the surface antigens of an arthritogenic Mycoplasma hominis strain.
  • To investigate the antigenic diversity of M. hominis strains using monoclonal antibodies.

Main Methods:

  • Preparation of monoclonal antibodies against Mycoplasma hominis.
  • Immunoblotting and Triton X-114 phase partitioning to identify surface-exposed, hydrophobic polypeptides.
  • Radiolabeling with [14C]palmitate to assess protein acylation.
  • Testing antibody reactivity against multiple M. hominis strains.

Main Results:

  • Predominant antigenic determinants were found on surface-exposed, hydrophobic polypeptides.
  • Evidence suggested potential acylation of these proteins.
  • While antigenic heterogeneity was observed, a 94-kDa protein was recognized by at least one MAb in 16 of 17 strains.
  • All strains expressed epitopes recognized by the MAbs, albeit on different proteins.

Conclusions:

  • Mycoplasma hominis possesses surface-exposed, potentially acylated proteins that serve as antigenic targets.
  • Apparent antigenic diversity among strains may mask conserved epitopes, suggesting mechanisms for generating antigenic variation.